BLACK DIAMOND THERAPEUTICS, INC. Deferred Tax Liabilities, Leasing Arrangements
BLACK DIAMOND THERAPEUTICS, INC. (BDTX) had Deferred Tax Liabilities, Leasing Arrangements of $2.47 million as of 2025-12-31, per its 10-K filed 2026-03-16.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Liabilities, Gross
us-gaap:DeferredTaxLiabilitiesLeasingArrangements · last filed 2026-03-16
- 2025-12-31: Deferred Tax Liabilities, Leasing Arrangements $2.47M.
- 2024-12-31: Deferred Tax Liabilities, Leasing Arrangements $4.64M.
- 2023-12-31: Deferred Tax Liabilities, Leasing Arrangements $5.84M.
- 2022-12-31: Deferred Tax Liabilities, Leasing Arrangements $6.39M.
| Period end | Deferred Tax Liabilities, Leasing Arrangements |
|---|---|
| 2025-12-31 | $2.47M 10-K · filed 2026-03-16 |
| 2024-12-31 | $4.64M 10-K · filed 2026-03-16 |
| 2023-12-31 | $5.84M 10-K · filed 2025-03-06 |
| 2022-12-31 | $6.39M 10-K · filed 2024-03-12 |
| 2021-12-31 | $7.24M 10-K · filed 2023-03-09 |
| 2020-12-31 | $2.06M 10-K · filed 2022-03-17 |
| 2019-12-31 | $0.00 10-K · filed 2021-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |